US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 3.2600
  • +0.1300+4.15%
Close Nov 18 16:00 ET
  • 3.2600
  • 0.00000.00%
Post 20:01 ET
12.44MMarket Cap-483P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Total revenue
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-23.74%11.81M
30.54%15.48M
415.82%11.86M
-45.21%2.3M
21.69%4.2M
-40.19%3.45M
5.77M
Selling and administrative expenses
-9.33%5.9M
9.50%6.51M
170.08%5.94M
-33.32%2.2M
20.39%3.3M
90.05%2.74M
--1.44M
-General and administrative expense
-9.33%5.9M
9.50%6.51M
170.08%5.94M
-33.32%2.2M
20.39%3.3M
90.05%2.74M
--1.44M
Research and development costs
-34.18%5.91M
51.65%8.98M
5,844.42%5.92M
-88.91%99.58K
26.72%897.79K
-83.62%708.46K
--4.32M
Operating profit
23.74%-11.81M
-30.54%-15.48M
-415.82%-11.86M
45.21%-2.3M
-21.69%-4.2M
40.19%-3.45M
-5.77M
Net non-operating interest income expense
-43.91%-145.15K
-48.04%-100.87K
70.85%-68.13K
71.49%-233.7K
24.43%-819.71K
-21.82%-1.08M
-890.4K
Non-operating interest expense
43.91%145.15K
48.04%100.87K
-70.85%68.13K
-71.49%233.7K
-24.43%819.71K
21.82%1.08M
--890.4K
Other net income (expense)
75.91%-219.81K
-5,167.27%-912.45K
94.72%-17.32K
23.71%-328.37K
29.81%-430.4K
-613.2K
Special income (charges)
--0
---922.5K
--0
--0
42.00%-364.95K
---629.23K
--0
-Less:Other special charges
----
--922.5K
----
----
-42.00%364.95K
--629.23K
----
Other non- operating income (expenses)
-2,288.27%-219.81K
157.99%10.05K
94.72%-17.32K
-401.74%-328.37K
-508.14%-65.45K
--16.04K
----
Income before tax
26.21%-12.17M
-38.08%-16.5M
-317.49%-11.95M
47.47%-2.86M
-5.84%-5.45M
22.69%-5.15M
-6.66M
Income tax
Net income
26.21%-12.17M
-38.08%-16.5M
-317.49%-11.95M
47.47%-2.86M
-5.84%-5.45M
22.69%-5.15M
-6.66M
Net income continuous Operations
26.21%-12.17M
-38.08%-16.5M
-317.49%-11.95M
47.47%-2.86M
-5.84%-5.45M
22.69%-5.15M
---6.66M
Minority interest income
Net income attributable to the parent company
26.21%-12.17M
-38.08%-16.5M
-317.49%-11.95M
47.47%-2.86M
-5.84%-5.45M
22.69%-5.15M
-6.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.21%-12.17M
-38.08%-16.5M
-317.49%-11.95M
47.47%-2.86M
-5.84%-5.45M
22.69%-5.15M
-6.66M
Basic earnings per share
61.90%-12.8
16.00%-33.6
-270.32%-40
41.61%-10.8016
-4,133.46%-18.4974
22.69%-0.4369
-0.5652
Diluted earnings per share
61.90%-12.8
16.00%-33.6
-270.32%-40
41.61%-10.8016
-4,133.46%-18.4974
22.69%-0.4369
-0.5652
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2023 (FY)Dec 31, 2022 (FY)Dec 31, 2021 (FY)Dec 31, 2020 (FY)Dec 31, 2019 (FY)Dec 31, 2018 (FY)Dec 31, 2017
Total revenue 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense -23.74%11.81M 30.54%15.48M 415.82%11.86M -45.21%2.3M 21.69%4.2M -40.19%3.45M 5.77M
Selling and administrative expenses -9.33%5.9M 9.50%6.51M 170.08%5.94M -33.32%2.2M 20.39%3.3M 90.05%2.74M --1.44M
-General and administrative expense -9.33%5.9M 9.50%6.51M 170.08%5.94M -33.32%2.2M 20.39%3.3M 90.05%2.74M --1.44M
Research and development costs -34.18%5.91M 51.65%8.98M 5,844.42%5.92M -88.91%99.58K 26.72%897.79K -83.62%708.46K --4.32M
Operating profit 23.74%-11.81M -30.54%-15.48M -415.82%-11.86M 45.21%-2.3M -21.69%-4.2M 40.19%-3.45M -5.77M
Net non-operating interest income expense -43.91%-145.15K -48.04%-100.87K 70.85%-68.13K 71.49%-233.7K 24.43%-819.71K -21.82%-1.08M -890.4K
Non-operating interest expense 43.91%145.15K 48.04%100.87K -70.85%68.13K -71.49%233.7K -24.43%819.71K 21.82%1.08M --890.4K
Other net income (expense) 75.91%-219.81K -5,167.27%-912.45K 94.72%-17.32K 23.71%-328.37K 29.81%-430.4K -613.2K
Special income (charges) --0 ---922.5K --0 --0 42.00%-364.95K ---629.23K --0
-Less:Other special charges ---- --922.5K ---- ---- -42.00%364.95K --629.23K ----
Other non- operating income (expenses) -2,288.27%-219.81K 157.99%10.05K 94.72%-17.32K -401.74%-328.37K -508.14%-65.45K --16.04K ----
Income before tax 26.21%-12.17M -38.08%-16.5M -317.49%-11.95M 47.47%-2.86M -5.84%-5.45M 22.69%-5.15M -6.66M
Income tax
Net income 26.21%-12.17M -38.08%-16.5M -317.49%-11.95M 47.47%-2.86M -5.84%-5.45M 22.69%-5.15M -6.66M
Net income continuous Operations 26.21%-12.17M -38.08%-16.5M -317.49%-11.95M 47.47%-2.86M -5.84%-5.45M 22.69%-5.15M ---6.66M
Minority interest income
Net income attributable to the parent company 26.21%-12.17M -38.08%-16.5M -317.49%-11.95M 47.47%-2.86M -5.84%-5.45M 22.69%-5.15M -6.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.21%-12.17M -38.08%-16.5M -317.49%-11.95M 47.47%-2.86M -5.84%-5.45M 22.69%-5.15M -6.66M
Basic earnings per share 61.90%-12.8 16.00%-33.6 -270.32%-40 41.61%-10.8016 -4,133.46%-18.4974 22.69%-0.4369 -0.5652
Diluted earnings per share 61.90%-12.8 16.00%-33.6 -270.32%-40 41.61%-10.8016 -4,133.46%-18.4974 22.69%-0.4369 -0.5652
Dividend per share
Currency Unit USD USD USD USD USD USD USD
Audit Opinions Unqualified Opinion with Explanatory Notes Unqualified Opinion Unqualified Opinion Unqualified Opinion with Explanatory Notes Unqualified Opinion with Explanatory Notes -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data